ARCHIVES

BMS Settles Charges Of Obstructing Generics

This article is from The Cancer Letter archive.

Vol. 29 No. 11 | March 14, 2003

Download PDF Visit The Full Archive

Related Articles

NCI Advisors Approve New $5 Million Program For Reagent Contracts.

July 10, 2009

US Oncology Inc. Asked For Drug Purchase Information.

July 4, 2003

DCT Board Approves More Than $25 Million In Contract Recompetitions, Two New Contracts

February 23, 1990

Academies Updates Guidelines on Stem Cell Research. NIH Begins New T-R01 Program.

September 19, 2008

UT System Launches Probe of Submission Of Controversial MD Anderson Grant

June 8, 2012

Seattle Cancer Care Alliance Outpatient Clinic to Open – Jan. 19, 2001

June 7, 2021